[1]Sørensen A H, Hansen L H, Johannesen E, Sørensen S J. Conjugative plasmid conferring resistance to olaquindox. Antimicrobial Agents and Chemotherapy, 2003, 47:798-799.
[2]Hansen L H, Johannesen E, Burmolle M, Sørensen A H, Sørensen S J. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrobial Agents and Chemotherapy, 2004, 48: 3332-3337.
[3]Norman A, Hansen L H, She Q X, Sørensena S J. Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid, 2008, 60: 59-74.
[4]Hansen L H, Jensen L B, Sørensen H I, Sørensen S J. Substrate specificity of the oqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. Antimicrobial Agents and Chemotherapy, 2007, 60:145–147.
[5]Kim H B, Wang M, Park C H, Kim E C, Jacoby G A, Hooper D C. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob. Agents Chemother, 2009, 53: 3582-3584.
[6]Strahilevitz J, JacobyG A, Hooper D C, Robicsek A. Plasmid- mediated quinolone resistance: a multifacete threat. Clinical Microbiology Reviews, 2009, 22:664-689.
[7]Martínez-Martínez L, Pascual A, Jacoby G A. Quinolone resistance
from a transferable plasmid. Lancet, 1998, 351: 797-799.
[8]Hata M, Suzuki M, Matsumoto M, Takahashi M, Sato K, Ibe S, Sakae
K. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrobial Agents and Chemotherapy, 2005, 49: 801-803.
[9]Jacoby G A, Walsh K E, Mills D M, Walker V J, Oh H, Robicsek A,
Hooper D C. qnrB, another plasmid-mediated gene for quinolone
resistance. Antimicrobial Agents and Chemotherapy, 2006, 50: 1178-1182.
[10]Robicsek A, Strahilevitz, Jacoby G A, Macielag M, Abbanat D, Park C H, Bush K, Hooper D C. Fluoroquinolone modifying enzyme: a novel adaptation of a common aminoglycoside acetyltransferase. Nature Medicine, 2006, 12: 83-88.
[11]Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T, Arakawa Y. New plasmid-mediated fluoroquinolone efflux Pump, QepA, found in an Escherichia coliclinical isolate. Antimicrobial Agents and Chemotherapy, 2007, 51:3354-3360.
[12]Zhao J, Chen Z, Chen S, Deng Y, Liu Y, Tian W, Huang X, Wu C, Sun Y, Sun Y, Zeng Z, Liu J H. Prevalence and Dissemination of oqxAB in Escherichia coli Isolates from Animals, Farmworkers, and the Environment. Antimicrobial Agents and Chemotherapy, 2010, 54(10): 4219- 4224.
[13]Cambau E, Lascols C, Sougakoff W, Bébéar C, Bonnet R, Cavallo J D, Gutmann L, Ploy M C, Jarlier V, Soussy C J, Robert J. Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005. Clinical Microbiology and Infection, 2006, 12(10): 1013-1020.
[14]Poirel L, Pitout J D D, Calvo L, Rodriguez-Martinez J M, Church D, Nordmann P. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase. Antimicrobial Agents and Chemotherapy, 2006, 50(4): 1525-1527.
[15]Ma, J, Zeng, Z, Chen, Z, Xu, X, Wang, X, Deng, Y, Lü, D, Huang, L, Zhang, Y, Liu, J, Wang, M. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6’)-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolatesceae isolates from companion and food-producing animals. Antimicrobial Agents and Chemotherapy, 2009, 53:519-524.
[16]杜向党, 连明香, 李德喜, 张素梅, 刘建华, 潘玉善, 李新生. 质粒介导的喹诺酮类耐药基因在猪源大肠杆菌中的检测. 江西农业学报, 2009, 21(8): 9-11.
Du X D, Lian M X, Li D X, Zhang S M, Liu J H, PianY S, Li X S.Detection of plasmid-mediated quinolone resistance among Escherichia coli isolates from pigs. Jiangxi Journal of Agricultural Sciences, 2009, 21(8): 9-11.(in Chinese)
[17]Wang M, Tran J H, Jacoby G A, Zhang Y, Wang F, Hooper D C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai China. Antimicrobial Agents and Chemotherapy, 2003, 47: 2242-2248.
[18]赵 旭, 徐晓刚, 王明贵. 阴沟肠杆菌临床分离株中3类质粒介导喹诺酮类药物耐药基因检测. 中国感染与化疗杂志, 2009, 9(3): 210-215.
Zhao X, Xu X G, Wang M G. Detection of three kinds of plasmid-mediated quinolone resistance among Enterobacter cloacae. Chinese Journal of Infection and Chemotherapy, 2009, 9(3): 210-215. (in Chinese)
[19]Yue L, Jiang H X, Liao X P, Liu J H, Li S J, Chen X Y, Chen C X, Lu D H, Liu Y H. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli. Veterinary Microbiology, 2008, 132(3-4): 414-420.
[20]Wu J, Ko W, Tsai S, Yan J. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolatesof Enterobacter cloacae in a Taiwanese hospital. Antimicrobial Agents and Chemotherapy, 2007, 49: 1223-1227.
[21]Jonas D, Biehler Y, Hartung D, Spitzmuller B, Daschner F D. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrobial Agents and Chemotherapy, 2005, 49(2):773-775.
[22]Poirel L, Rodriguez-Martinez J, Mammeri H, Liard A, Nordmann P.
Origin of plasmid-mediated quinolone resistance determinant QnrA.
Antimicrobial Agents and Chemotherapy, 2005, 49: 3523-3525.
[23]Kim H B, Park C H, Kim C J, Kim E C, JacobyG A, Hooper D C. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-Year Period. Antimicrobial Agents and Chemotherapy, 2009, 53(2): 639-645.
[24]Wu C M, Wang Y, Cao X Y, Lin J C, Qin S S, Mi T J, Huang S Y, Shen J Z.. Emergence of plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolated from chickens in China. Journal of Antimicrobial Chemotherogy, 2009, 63(2):409-411.
[25]Xiao Y H, Wang J, Li Y. Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005. European Journal of Clinical Microbiology, 2008, 27:697-708.
[26]Yang H C, Chen S, White D G, Zhao S H, McDermott P, Walker R, Meng J H. Characterization of multiple- antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China. Journal of Clinical Microbiology, 2004, 42:3483-3489. |